Research Topics
| Robert Y LinSummaryAffiliation: St. Vincent's Country: USA Publications
|
Detail Information
Publications
Drug-induced, dementia-associated and non-dementia, non-drug delirium hospitalizations in the United States, 1998-2005: an analysis of the national inpatient sampleRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan SVCMC, 153 West 11th Street, New York, NY 10011, USA
Drugs Aging 27:51-61. 2010....- Incidence and impact of adverse effects to antibiotics in hospitalized adults with pneumoniaRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan Saint Vincent Catholic Medical Centers, New York, New York 10011, USA
J Hosp Med 4:E7-15. 2009..This study sought to define the incidence, economic impact, and nature of adverse drug effects (ADEs) related to antibiotics in pneumonia hospitalizations in the US... - Increasing hospitalizations due to angioedema in the United StatesRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan, Saint Vincent Catholic Medical Centers, New York, New York 10011, USA
Ann Allergy Asthma Immunol 101:185-92. 2008..With the more prevalent use of this class of medications in the United States, it is not known whether angioedema hospitalizations have increased nationally in recent years... - Clinical associations of delirium in hospitalized adult patients and the role of on admission presentationRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan SVCMC, New York, NY, USA
Int J Geriatr Psychiatry 25:1022-9. 2010..To describe clinical associations of delirium in hospitalized patients and relationships to on admission presentation... - Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008Robert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan SVCMC, New York, New York 10011, USA
Ann Allergy Asthma Immunol 103:442-5. 2009..Anaphylaxis associated with omalizumab treatment is a growing concern. The broader context in which omalizumab-associated allergic reactions occur has not been well described... - Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990 -2006Robert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan SVCMC, New York, New York 10011, USA
Ann Allergy Asthma Immunol 101:387-93. 2008..Background: Although an increase in the occurrence of anaphylaxis has been reported in several parts of the world, this phenomenon has not been described in the United States... - The gender disparity in adult asthma hospitalizations dynamically relates to ageRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan SVCMC, New York Medical College, New York, NY 10011, USA robert
J Asthma 45:931-5. 2008..The gender gap in hospitalization rates appears to be maximal between the ages of 40 and 54. This may reflect age related asthma prevalence and/or severity differences between men and women... 
Asthma hospitalization patterns in young children relating to admission age, infection presence, sex, and raceRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan, Saint Vincent Catholic Medical Centers, New York, New York 10011, USA
Ann Allergy Asthma Immunol 98:139-45. 2007..Although childhood hospitalizations for asthma are common, there are few detailed temporal and demographic descriptions of these hospitalizations...- Pattern of hospitalizations for angioedema in New York between 1990 and 2003Robert Y Lin
New York Medical College, Valhalla, New York, USA
Ann Allergy Asthma Immunol 95:159-66. 2005..This fact is particularly relevant given the increased use of angiotensin-converting enzyme inhibitors, a known cause of angioedema... - Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumabRobert Y Lin
Department of Medicine, St Vincent s Hospital Manhattan Saint Vincent s Catholic Medical Centers, New York, New York, USA
J Asthma 47:942-5. 2010..The ability to assess adequate reductions in immunoglobulin E (IgE) in allergic bronchopulmonary aspergillosis (ABPA) has been a concern with regards to omalizumab treatment...